During a bronchoscopy, a doctor passes a bronchoscope, a thin, flexible tube mounted with a small light and camera, through the nose or mouth of the patient and into the airways of the lungs. Using the light and the camera, the doctor can both see the airways and take pictures.
A navigational bronchoscopy uses a special bronchoscope to examine and treat lesions in areas of the lungs that are inaccessible using a regular bronchoscope. Navigational bronchoscopy combines electromagnetic navigation with real-time computed tomography (CT) images to create a three-dimensional map of the lungs. Doctors are then able to use this map to guide the navigational bronchoscope, which includes an extended working channel and guide wire, to difficult-to-access areas of the lungs to take a biopsy or help guide radiation therapy directly to a hard-to-reach lesion. At ACMH, navigational bronchoscopy is performed in an outpatient setting – most patients return home the same day as the procedure.
Endobronchial ultrasound (EBUS) is a procedure that uses ultrasound technology in combination with bronchoscopy to visualize the walls of the airways and surrounding structures. EBUS allows doctors to locate hard-to-reach tumors and small cell lung cancer. EBUS can also be used to take a biopsy from tissue in the lungs or from the surrounding lymph nodes in the chest.
Reflex sufferers, meet LINX® -- a revolutionary solution for reflux. It's a simple device with life-changing potential. LINX is intended for patients diagnosed with reflux disease who continue to suffer symptoms despite taking medication.
Reflux (also called Gastroesophageal Reflux Disease, or GERD) is caused by a weak muscle in your esophagus called the Lower Esophageal Sphincter (LES) that allows acid and bile to flow back from the stomach into the esophagus, causing damage to the lining of the esophagus, throat and lungs.
The LINX Solution
LINX is easy to understand and love because it is simple. LINX is a small, flexible ring of magnets that opens to allow food and liquid down, then closes to prevent stomach contents from moving up. Simple as that.
The LINX procedure is the first non-medical surgical therapy to be approved for gastroesophageal reflux disease (GERD) by the Food and Drug Administration in more than three decades. LINX uses a small, flexible band of magnets enclosed in titanium beads to regulate a weak lower esophageal sphincter (LES) and mimic a natural barrier to reflux. The bracelet is placed around the base of the esophagus. When food or liquid passes through, the band expands. The magnetic bond then allows the beads to close after swallowing, preventing gastric juices from refluxing back into the esophagus.
The LINX procedure is performed laparoscopically on an outpatient basis and typically takes 30 minutes to an hour to complete. Patients are placed under general anesthesia.
Most patients fully recover from the procedure in about a week and can resume their normal diet soon afterward. Side effects are generally minimal and resolve over time.
Dr. Rodney Landreneau joined the ACMH medical staff in late summer of 2015. An internationally recognized thoracic surgeon, he brings a wealth of experience to our region. Throughout his career, Dr. Landreneau's clinical and research focuses have been directed toward minimally invasive surgical treatment of lung cancer, esophageal cancer and benign esophageal diseases.
In 2016, ACMH established the Advanced Center for Lung and Esophageal Disorders. A team of highly skilled surgeons, physicians and pulmonologists – including Dr. Landreneau, Dr. Blair Jobe and UPMC Pulmonary Consultants – work seamlessly to bring you innovative procedures and techniques for gastric, digestive and lung disorders. Cutting-edge treatment technologies offer solutions that are minimally invasive, resulting in quicker recovery times.
One of the nation's preeminent esophageal disease specialists, Dr. Blair Jobe has brought his expertise to our community as part of a collaboration with Allegheny Health Network. He is performing the LINX procedure on-site at ACMH. He is also an integral part of the ACMH Advanced Center for Lung and Esophageal Disorders.
Dr. Jobe is widely considered one of the country's leading specialists and pioneers in the field of minimally invasive surgery and endoscopic therapy for the treatment of esophageal cancer, Barrett's esophagus, esophageal motility disorders and gastroesophageal reflux disease (GERD). At UPMC, he created the Esophageal Diagnostic Center, a program designed to provide cutting edge diagnostic and therapeutic options for complex esophageal and gastric disorders, and developed the Barrett's Esophagus Risk Consortium, a highly successful NIH-funded cancer and Barrett's screening program. He is also the director of the AHN Esophageal and Lung Institute.
Dr. Jobe’s office is conveniently located at Suite 110 on the ACMH campus. Call 724-548-5002 to schedule your consultation.